BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18990887)

  • 1. [Analysis of actual costs in long-term therapy of reflux disease. Use of pantoprazole counts].
    MMW Fortschr Med; 2008 Oct; 150(40):52-3. PubMed ID: 18990887
    [No Abstract]   [Full Text] [Related]  

  • 2. [Decreased need for tablets with pantoprazole. PPI: independent study questions savings through use of generic drugs].
    MMW Fortschr Med; 2007 Dec; 149(49-50):58. PubMed ID: 18236985
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of gastric acid-induced illnesses in general practice. The first pantoprazole generic drug has arrived].
    MMW Fortschr Med; 2009 Jan; 151(5):46-7. PubMed ID: 19391415
    [No Abstract]   [Full Text] [Related]  

  • 4. [Proton pump inhibition: more than only reflux therapy].
    MMW Fortschr Med; 2008 Nov; 150(46):48-9. PubMed ID: 19133361
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cost comparative analysis of drug therapy for non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcer in Japan].
    Hashiguchi M; Yamauchi N; Uchikura T; Mochizuki M
    Yakugaku Zasshi; 2008 Apr; 128(4):585-94. PubMed ID: 18379175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generics offer pharmacy plans specific benefits.
    Reinke T
    Manag Care; 2010 Feb; 19(2):28-30, 34. PubMed ID: 20550049
    [No Abstract]   [Full Text] [Related]  

  • 7. Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients.
    Calabrese C; Liguori G; Gabusi V; Gionchetti P; Rizzello F; Straforini G; Brugnera R; Di Febo G
    Aliment Pharmacol Ther; 2008 Jul; 28(2):250-5. PubMed ID: 18485128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [General practitioners' management of gastroesophageal reflux in France in 2005: a pharmacoeconomic study].
    Mouly S; Charlemagne A; Le Jeunne P; Fagnani F
    Presse Med; 2008 Oct; 37(10):1397-406. PubMed ID: 18502602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pantoprazole available without a prescription: new status. Better than H2 receptor agonists, but not for pregnant women.
    Prescrire Int; 2009 Dec; 18(104):250. PubMed ID: 20025090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medical treatment efficient in chronic reflux. Also surgery has a given place in long-term therapy--for certain patients].
    Lundell L
    Lakartidningen; 2009 Feb 18-24; 106(8):502-5. PubMed ID: 19350782
    [No Abstract]   [Full Text] [Related]  

  • 11. The acid test for formulary policy.
    McCaffrey E
    Bus Health; 1999 Dec; 17(12 Suppl A):19-24. PubMed ID: 10747676
    [No Abstract]   [Full Text] [Related]  

  • 12. A pharmacoeconomic comparison of the efficacy and costs of pantoprazole and omeprazole for the treatment of peptic ulcer or gastroesophageal reflux disease in The Netherlands.
    van Hout BA; Klok RM; Brouwers JR; Postma MJ
    Clin Ther; 2003 Feb; 25(2):635-46. PubMed ID: 12749518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BUDGET IMPACT ANALYSIS OF USING OMEPRAZOLE IMMEDIATE-RELEASE ORAL SUSPENSION IN REPLACE OF INTRAVENOUS PANTOPRAZOLE IN CRITICALLY ILL PATIENTS.
    Foroutan N; Fahimi F; Dabiri Y; Foroutan A; Habibi M; Salamzadeh J
    J Popul Ther Clin Pharmacol; 2015 Dec; 22(3):e292-e302. PubMed ID: 28414416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of 24-hour intragastric acidity with morning dosing of immediate-release and delayed-release proton pump inhibitors in patients with GERD.
    Howden CW; Ballard ED; Koch FK; Gautille TC; Bagin RG
    J Clin Gastroenterol; 2009 Apr; 43(4):323-6. PubMed ID: 18758373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug treatment and surgical indications in gastroesophageal reflux].
    PĂ©rez-Manauta J
    Rev Gastroenterol Mex; 2007 Nov; 72 Suppl 2():13-6. PubMed ID: 18277473
    [No Abstract]   [Full Text] [Related]  

  • 16. Pantoprazole: a proton pump inhibitor with oral and intravenous formulations.
    Devault KR
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):197-205. PubMed ID: 19072410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors.
    Miner PB; McKean LA; Gibb RD; Erasala GN; Ramsey DL; McRorie JW
    Aliment Pharmacol Ther; 2010 Apr; 31(8):846-51. PubMed ID: 20146702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of three alternative treatment strategies after 8 weeks of proton pump inhibitor therapy for GERD in children.
    Lee JH; Kim MJ; Lee JS; Choe YH
    Arch Dis Child; 2011 Jan; 96(1):9-13. PubMed ID: 20870626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on managed care--pharmacoeconomics and its application to antisecretory drugs: a case study.
    Morreale A
    Manag Care Interface; 2001; Suppl B():28-30; discussion 31-3. PubMed ID: 11569296
    [No Abstract]   [Full Text] [Related]  

  • 20. OTC omeprazole for your heartburn--enormous value-for-money opportunity.
    Curtiss FR
    J Manag Care Pharm; 2004; 10(5):458-60. PubMed ID: 15369431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.